<unk>  is a novel antiviral currently being studied in clinical trials for use in COVID-19. It was initially developed for treatment of Ebola and has also been shown to have some effect on SARS and MERS, as well as some other RNA viruses.
Remdesivir
Ritonavir
Molnupiravir
Lopinavir
Foscarnet
Raltegravir
Baloxavir marboxil
Ribavirin